Takeda Pharmaceutical Reports First Quarter Financial Results
Takeda Pharmaceutical (NYSE: TAK) reported its first-quarter financial results, showing a year-over-year increase in earnings per share to ¥154 from ¥151. However, the company experienced a significant drop in revenue to ¥1.22 trillion compared to the previous year. The operating profit rose by 11.5% to ¥358.9 billion, with an operating margin of 29.4%, up slightly from 29.1%. Despite these gains, Takeda's earnings per share declined in constant currency terms (-11.8%) and its revenue dropped nearly entirely year-over-year. The mixed performance highlights challenges faced by the company amid fluctuating exchange rates and market conditions. The net profit for Q1 was reported at ¥242.9 billion, reflecting a complex financial landscape where operational efficiency improvements were offset by external pressures.
Tickers: $TAK
Topics: financial_performance pharmaceuticals